CARG and CRASH Scores May Be Ineffective for Older Cancer Patients
The CARG and CRASH scoring systems were not predictive of severe adverse events in older patients receiving chemotherapy.
Diagnosis & Disease Information
The Burden and Current Management of Cisplatin-Induced Ototoxicity
A recent review highlights the burden of cisplatin-induced ototoxicity and the current state of monitoring and managing this condition.
Time From Biopsy to Skin Cancer Surgery Negatively Affected by Patient Perceptions of Delay
A survey study explored the effect of patient perception of a delay in skin cancer surgery on time between biopsy and surgery and patient-reported anxiety.
Anti-GPRC5D CAR-T Therapy Elicits Responses After Anti-BCMA CAR Failure
Anti-GPRC5D CAR T-cell therapy can produce responses in patients with relapsed or refractory multiple myeloma, a phase 2 trial suggests.
Erythema Multiforme Linked to Current or Recent Radiation Therapy for Cancer
Researchers investigated a possible connection between radiotherapy and development of erythema multiforme, in a single-institution case series.
ICD Codes Unreliable for Identifying Cardiovascular Events in ICI-Treated Patients
Researchers sought to determine CV event occurrence in patients treated with immune checkpoint inhibitors and assess the accuracy of diagnosis by ICD code compared with adjudication using established definitions.
Standardized Screening Increases Recognition of Distress in Patients With Cancer
A Plan-Do-Study-Act approach was used to validate a tool for measuring distress and clinical depression in patients with cancer.
Proteinuria, AKI With New Tyrosine Kinase Inhibitors Characterized
Since FDA approval of imtainib, 40 newer tyrosine kinase inhibitor agents have been approved.
Analysis of Sacituzumab Govitecan Shows Manageable Safety Profile in mTNBC
Researchers report on the safety data from the phase 3 ASCENT trial of sacituzumab govitecan in the treatment of metastatic triple-negative breast cancer.
Long-Term Outcomes Worse After Recovery From Severe Acute Graft-versus-Host Disease
A retrospective chart review demonstrated the long-term outcomes for patients with a history of grade 3-4 acute GVHD, compared with grade 0-1, after hematopoietic cell transplantation.
- Loading...
Loading...
Next post in Side-Effect Management
Loading... 
Loading...